Skip to main content

Cytek Biosciences, Inc 8-K, filed Nov 4, 2026

Cytek Biosciences, Inc. (CTKB)

8-K 2026-11-04 For: 2026-11-04
View Original
Added on November 04, 2026

About this 8-K

Cytek Biosciences, Inc filed this 8-K on November 4, 2026.

Cytek Biosciences reported third-quarter revenue of $53.2 million, up 2%, GAAP gross margin of 59% and a net loss of $6.1 million; full-year revenue guidance was narrowed to $208 million to $211 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits